Eating Disorders: Types, Warning Signs, and Treatment

Eating disorders are serious, diagnosable psychiatric conditions characterized by persistent disturbances in eating behavior and related thoughts and emotions. This page covers the major recognized disorder types, their defining diagnostic criteria, observable warning signs, and the structured frameworks used to organize clinical treatment. The scope draws from the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and guidance from the National Institute of Mental Health (NIMH) and the American Psychiatric Association (APA). These conditions carry among the highest mortality rates of any psychiatric diagnoses, making accurate classification and timely intervention clinically significant.

Definition and scope

Eating disorders are classified within the DSM-5 chapter titled "Feeding and Eating Disorders," which the American Psychiatric Association formally revised in 2013 to expand diagnostic categories beyond the historically narrow anorexia/bulimia binary. The National Institute of Mental Health estimates that eating disorders affect at least 9 percent of the global population at some point in their lifetime, though U.S.-focused epidemiological data suggest approximately 28.8 million Americans will meet diagnostic criteria for an eating disorder across their lifespan (NIMH, Eating Disorders).

Eating disorders are distinct from disordered eating — a subclinical pattern of irregular or problematic eating behavior that does not meet full diagnostic thresholds. Clinical diagnosis requires documented functional impairment, persistence of symptoms, and ruling out other medical or psychiatric explanations. These conditions frequently co-occur with anxiety disorders, depression, and substance use disorders and co-occurring mental health conditions, complicating both identification and treatment planning.

The DSM-5 recognizes the following primary diagnoses within this chapter:

1. Anorexia Nervosa (AN) — Restriction of energy intake leading to significantly low body weight, intense fear of weight gain, and disturbed body image.
2. Bulimia Nervosa (BN) — Recurrent episodes of binge eating followed by compensatory behaviors (purging, fasting, excessive exercise), occurring at least once per week for 3 months.
3. Binge Eating Disorder (BED) — Recurrent binge eating without compensatory behaviors; currently the most prevalent eating disorder in the U.S.
4. Avoidant/Restrictive Food Intake Disorder (ARFID) — Food avoidance or restriction not driven by body image disturbance; significant nutritional deficiency or weight loss results.
5. Other Specified Feeding or Eating Disorder (OSFED) — Clinically significant presentations that do not meet full criteria for the above categories.
6. Pica and Rumination Disorder — Less prevalent conditions involving non-nutritive substance ingestion and repeated regurgitation, respectively.

How it works

Eating disorders arise from a documented interaction of genetic, neurobiological, psychological, and sociocultural factors. Twin studies cited by the National Eating Disorders Association (NEDA) indicate heritability estimates of 50–83 percent for anorexia nervosa, placing it among the most heritable of all psychiatric conditions.

At the neurobiological level, dysregulation in serotonin and dopamine pathways affects reward processing, impulse control, and satiety signaling. The APA's Practice Guideline for the Treatment of Patients with Eating Disorders (Third Edition) identifies these neurobiological mechanisms as central to why behavioral interventions alone are often insufficient at the acute stage without medical stabilization.

Anorexia vs. Bulimia — a key contrast: Anorexia nervosa is characterized by restriction and low body weight, with two subtypes — restricting type and binge-eating/purging type. Bulimia nervosa, by contrast, occurs across the full weight spectrum and centers on the binge-purge cycle. Both share cognitive distortion around body image, but anorexia involves an ego-syntonic relationship with restriction (the behavior feels consistent with the person's goals), while bulimia more typically involves ego-dystonic shame and distress following binge episodes. This distinction shapes different treatment entry points and therapeutic targets.

Medical complications are organ-specific and serious. Electrolyte imbalances — particularly hypokalemia from purging — create cardiac arrhythmia risk. The Academy for Eating Disorders (AED) publishes medical care standards that identify refeeding syndrome as a primary medical risk in severely malnourished patients reintroducing nutrition. Bone density loss is measurable in patients with anorexia after 6–12 months of amenorrhea, per endocrinological literature cited in APA guidelines.

Common scenarios

Eating disorders manifest across demographic groups, though diagnostic patterns differ by population. Understanding these scenarios is relevant when consulting the mental health conditions overview or reviewing care-level options described under inpatient psychiatric care.

Adolescents and young adults: Onset of anorexia and bulimia peaks between ages 12 and 25 according to NIMH epidemiological data. Warning signs in this group include significant weight change, food rituals, withdrawal from meals, and declining academic or social functioning. The mental health services for children and adolescents framework addresses age-specific screening considerations.

Adults with BED: Binge eating disorder has a later average onset than AN or BN and is often underdiagnosed in adult primary care settings. The NIMH notes BED affects approximately 1.2 percent of U.S. adults in any 12-month period. Presentations frequently involve co-occurring mood disorders such as those described in the depression and mood disorders reference.

ARFID across the lifespan: ARFID is not restricted to children. Adults with autism spectrum conditions, anxiety disorders, or trauma histories may present with significant food restriction unrelated to weight or body image concerns. The diagnostic distinction between ARFID and AN is clinically critical because treatment protocols diverge substantially.

Warning signs — structured overview:

• Dramatic restriction of food variety or quantity without medical explanation
• Disappearing to bathrooms consistently after meals
• Hoarding or hiding food
• Wearing concealing clothing to hide body shape changes
• Preoccupation with food, calories, or body composition dominating conversation or behavior
• Fainting, dizziness, or cold intolerance (physiological indicators)
• Swollen jaw or dental erosion (indicative of purging behavior)

Decision boundaries

Clinical decision-making in eating disorder care involves two primary axes: diagnostic classification and level-of-care determination.

Diagnostic boundaries require distinguishing eating disorders from overlapping conditions. Obsessive food rituals can appear in obsessive-compulsive disorder (OCD), but OCD-driven food behavior is typically not tied to body image distortion. Social avoidance of meals may appear in social anxiety disorder without meeting ARFID criteria. Mood-driven appetite loss in major depression does not itself constitute an eating disorder. The DSM-5's exclusion criteria require ruling out general medical conditions (e.g., gastrointestinal disease) and other psychiatric diagnoses before assigning an eating disorder diagnosis.

Level-of-care criteria are structured through the ASAM-adjacent framework published by the American Psychiatric Association and the criteria developed by the Level of Care Utilization System (LOCUS) and ASAM for co-occurring psychiatric presentations. Eating disorder-specific level-of-care criteria are additionally codified in the ASAM/ACBS Medical Necessity Guidelines and the criteria published by the Eating Disorders Coalition. Decision thresholds include:

1. Medical stabilization (inpatient medical): Heart rate below 50 bpm, systolic blood pressure below 90 mmHg, or electrolyte values outside safe range.
2. Psychiatric inpatient: Active suicidality, inability to maintain safety, or failure at lower care levels.
3. Residential treatment: Medically stable but requiring 24-hour behavioral support; insufficient response to outpatient intervention.
4. Partial Hospitalization Program (PHP): Structured daily programming (typically 5–7 hours/day) without overnight stay; described in the partial hospitalization and intensive outpatient programs reference.
5. Intensive Outpatient Program (IOP): 3–5 days per week; appropriate for patients with adequate support systems and medical stability.
6. Standard outpatient: Weekly therapy and medical monitoring; appropriate for mild-to-moderate presentations with stable weight and no active purging.

Treatment modalities by diagnosis:

• Anorexia nervosa: Family-Based Treatment (FBT/Maudsley Approach) is the most evidence-supported intervention for adolescents; Enhanced Cognitive Behavioral Therapy (CBT-E) is first-line for adults per NICE guidelines (NICE Eating Disorders Guideline NG69).
• Bulimia nervosa: CBT-BN has the strongest evidence base; fluoxetine at 60 mg/day is the only FDA-approved pharmacological treatment for bulimia nervosa (FDA Drug Approvals Database).
• Binge eating disorder: CBT, Dialectical Behavior Therapy (DBT), and lisdexamfetamine (Vyvanse), the only FDA-approved medication for moderate-to-severe BED, are documented first-line options.
• ARFID: Exposure-based CBT adapted for sensory and anxiety-driven restriction is emerging as the leading protocol, though randomized controlled trial evidence remains limited as of the DSM